Lataa...
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy
Endocrine therapy is the mainstay of treatment of estrogen-receptor-positive (ER+) breast cancer with an overall survival benefit. However, some adaptive mechanisms in the tumor emerge leading to the development of a resistance to this therapy. A better characterization of this process is needed to...
Tallennettuna:
| Julkaisussa: | Ther Adv Med Oncol |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5424863/ https://ncbi.nlm.nih.gov/pubmed/28529550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017693195 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|